Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuanghui Yang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|July 18, 2022
Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid LeukemiaCheng Zhou, Zhiqin Wang, Shuanghui Yang, et al.
Plos One|January 26, 2016
ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 CellsGe Yu, Huan Li, Shuanghui Yang, et al.
Annals of Hematology|July 11, 2025
Cladribine and medium-dose cytarabine intensified busulfan plus cyclophosphamide conditioning regimen for adults high-risk B-cell acute lymphoblastic leukemiaTingting Cheng, Jie Peng, Yi Liu, et al.
Molecular Therapy. Nucleic Acids|October 7, 2018
Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological MalignanciesShuanghui Yang, Huan Li, Ling Xu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 27, 2019
Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive ImmunotherapyShuanghui Yang, Jianguo Wen, Huan Li, et al.
Theranostics|April 25, 2017
Aptamer Internalization via Endocytosis Inducing S-Phase Arrest and Priming Maver-1 Lymphoma Cells for Cytarabine ChemotherapyHuan Li, Shuanghui Yang, Ge Yu, et al.
ACS Sensors|August 13, 2019
Rapid Detection of Mycoplasma-Infected Cells by an ssDNA Aptamer ProbeYanting Liu, Wenqi Jiang, Shuanghui Yang, et al.
Stem Cells Translational Medicine|May 12, 2019
Anterior Cruciate Ligament Reconstruction in a Rabbit Model Using a Decellularized Allogenic Semitendinous Tendon Combined with Autologous Bone Marrow-Derived Mesenchymal Stem CellsWei Lu, Jian Xu, Shikui Dong, et al.
Molecular Therapy. Nucleic Acids|November 28, 2025
Multivalent aptamer engineered and functionalized NK cells for enhanced adoptive immunotherapy in CD30-positive malignant lymphomaFang Tan, Rui Wei, Jiqing Su, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|July 18, 2022
Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid LeukemiaCheng Zhou, Zhiqin Wang, Shuanghui Yang, et al.
Plos One|January 26, 2016
ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 CellsGe Yu, Huan Li, Shuanghui Yang, et al.
Annals of Hematology|July 11, 2025
Cladribine and medium-dose cytarabine intensified busulfan plus cyclophosphamide conditioning regimen for adults high-risk B-cell acute lymphoblastic leukemiaTingting Cheng, Jie Peng, Yi Liu, et al.
Molecular Therapy. Nucleic Acids|October 7, 2018
Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological MalignanciesShuanghui Yang, Huan Li, Ling Xu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 27, 2019
Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive ImmunotherapyShuanghui Yang, Jianguo Wen, Huan Li, et al.
Theranostics|April 25, 2017
Aptamer Internalization via Endocytosis Inducing S-Phase Arrest and Priming Maver-1 Lymphoma Cells for Cytarabine ChemotherapyHuan Li, Shuanghui Yang, Ge Yu, et al.
ACS Sensors|August 13, 2019
Rapid Detection of Mycoplasma-Infected Cells by an ssDNA Aptamer ProbeYanting Liu, Wenqi Jiang, Shuanghui Yang, et al.
Stem Cells Translational Medicine|May 12, 2019
Anterior Cruciate Ligament Reconstruction in a Rabbit Model Using a Decellularized Allogenic Semitendinous Tendon Combined with Autologous Bone Marrow-Derived Mesenchymal Stem CellsWei Lu, Jian Xu, Shikui Dong, et al.
Molecular Therapy. Nucleic Acids|November 28, 2025
Multivalent aptamer engineered and functionalized NK cells for enhanced adoptive immunotherapy in CD30-positive malignant lymphomaFang Tan, Rui Wei, Jiqing Su, et al.
Pageof 1